Smith & Nephew appoints Roland Diggelmann to its Board as Non-Executive Director

– UK, London – Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that Roland Diggelmann joined the Company on 1 March 2018 as Non-Executive Director and a member of the Audit Committee, as announced on 31 January 2018.

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE 100 (LSE:SN, NYSE:SNN).

For more information : http://www.smith-nephew.com

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.